Rituximab plus methotrexate-based chemotherapy (R-MPV) and whole-brain radiotherapy (WBRT) is promising for primary CNS lymphoma

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1613, 2007-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract